Following NICE guidance (MTG19)¹ recommending use of the geko™ device for VTE prophylaxis, we have adopted the geko™ for high-risk VTE patients where drugs or other mechanical methods of VTE prevention are contraindicated or impractical.

Through targeted evaluations, I have also explored use of the geko™ in the healing process for patients with chronic venous insufficiency. Of note, was the introduction of geko™ as an adjunct therapy in the care regime of Mr Gordon Vickers, a patient with a hard-to-heal mixed aetiology ulcer, where pain and immobility had impacted the severity of his leg ulceration.

Hospitalized twice over a 6 month period, geko™ device usage was introduced at week 35 and controlled to 6 hours a day, five days a week. The combined geko™ + compression wound therapy delivered a significant reduction in the observed oedema and an accelerated wound healing process, resulting in total wound closure at week 23 post geko™ introduction².

Mr Vickers treatment, also comprised of strong analgesia and antibiotics delivered intravenously, requiring hospital stays. Following geko™ use he reported improvements to quality of life and verbal pain rating, going from severe pain, to moderate, to low pain on treatment completion”.